16:13:20 EDT Tue 14 May 2024
Enter Symbol
or Name
USA
CA



Cannabix Technologies Inc
Symbol BLO
Shares Issued 114,144,104
Close 2024-04-24 C$ 0.445
Market Cap C$ 50,794,126
Recent Sedar Documents

Cannabix talks Breath Logix use by Friedel Clinic

2024-04-25 12:41 ET - News Release

Mr. Rav Mlait reports

CANNABIX'S BREATH LOGIX ALCOHOL DEVICE DELIVERS POSITIVE IMPACT TO PRIVATE MONITORING AGENCY IN MONTANA, USA

Friedel LLC (Friedel Clinic), a private monitoring agency based in Montana, has deployed Cannabix Technologies Inc.'s Breath Logix alcohol breathalyzer (formerly known as the CAB product offering) under its 24/7 Sobriety Program. Under the 24/7 Sobriety Program, participants, as a condition to their probation release, are scheduled for twice-daily alcohol breath testing at designated locations within the state. The company reports that the Breath Logix device has been used daily, collecting over 1,000 breath samples autonomously. The device captures user photos to confirm and record identity, and delivers near-instantaneous blood alcohol content (BAC) breath results.

Probation officer Neil Friedel stated: "In a relatively short period of time the Breath Logix device has become an invaluable device under our 24/7 Sobriety Program. The device allows our clients to autonomously get tested for breath alcohol without the need for our clinic to station a full-time administrator -- it's a game changer for us. Our clinic is saving time and money daily with the Breath Logix device deployed in our office. It has quickly become part of our daily routine and work flow process in our clinic."

The Friedel Clinic has a robust drug testing operation and is one of the top drug and alcohol testing providers to the judicial system and employers within the state of Montana. The high-volume clinic has a diverse range of patients and focuses on private sector testing for alcohol and illicit drugs.

24/7 Sobriety Program in the United States

Cannabix has been piloting its Breath Logix alcohol screening device as a new solution for the 24/7 Sobriety Program, which exists in several states in the United States. This program seeks to reduce the rearrests of individuals previously convicted of driving while under the influence (DUI) of alcohol or drugs through daily breath testing.

In a 24/7 Sobriety Program, offenders are scheduled for twice-daily alcohol testing at select locations in a given state or county. Currently the program requires dedicated employees to administer alcohol tests with a handheld alcohol breathalyzer throughout the day. The Breath Logix could revolutionize the program by delivering autonomous collection and reporting of alcohol results to administrators leading to significant savings and process efficiency.

Breath Logix industrial series features

The Breath Logix industrial series is a weather-resistant device with a host of requested features, including patent-pending precalibrated cartridge technology which will allow site safety administrators to easily maintain their devices, and eliminate the need for costly calibration equipment and time-consuming site visits from technicians for maintenance. This device can be used for preaccess alcohol testing, random testing, start-of-shift testing, pre-employment testing, return-to-work testing, postincident testing and for the 24/7 Sobriety Program.

The Breath Logix alcohol device automatically checks the sobriety of a user and can take a picture to confirm and record identity while a breath sample is being delivered. Upon detection of positive breath alcohol result, the device will deliver a precise BAC level on the screen, and send a real-time alert via text message, e-mail and to a dedicated Web portal. Furthermore, the system logs user BAC for incident reporting and historical investigations. The Breath Logix helps organizations save money by deploying an autonomous alcohol screening device which eliminates the need for dedicated alcohol screening administrators using conventional hand-held devices.

About Cannabix Technologies Inc.

Cannabix Technologies is a developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. Cannabix is developing delta-9 THC (tetrahydrocannabinol) and alcohol screening devices. Delta-9 THC is the psychoactive component of marijuana that causes impairment. Breath testing for delta-9 THC would allow employers and law enforcement to identify recent marijuana use. Cannabix is the developer of Breath Logix series of autonomous breath alcohol detection devices for employers and a range of other settings.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.